These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37138298)

  • 1. Uncovering the gray zone: mapping the global landscape of direct-to-consumer businesses offering interventions based on secretomes, extracellular vesicles, and exosomes.
    Asadpour A; Yahaya BH; Bicknell K; Cottrell GS; Widera D
    Stem Cell Res Ther; 2023 May; 14(1):111. PubMed ID: 37138298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-to-consumer marketing of stem cell interventions by Canadian businesses.
    Turner L
    Regen Med; 2018 Sep; 13(6):643-658. PubMed ID: 30255734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications.
    Gemayel J; Chaker D; El Hachem G; Mhanna M; Salemeh R; Hanna C; Harb F; Ibrahim A; Chebly A; Khalil C
    Clin Transl Oncol; 2023 Jul; 25(7):2056-2068. PubMed ID: 36808392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies.
    Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC
    Regen Med; 2023 Nov; 18(11):857-868. PubMed ID: 37867326
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies.
    Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC
    Regen Med; 2023 Oct; 18(10):781-793. PubMed ID: 37795701
    [No Abstract]   [Full Text] [Related]  

  • 6. The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine.
    Rahimi B; Panahi M; Saraygord-Afshari N; Taheri N; Bilici M; Jafari D; Alizadeh E
    Mol Biol Rep; 2021 Jul; 48(7):5607-5619. PubMed ID: 34191238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era.
    Turner L; Wang JC; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Sahrai V
    Cytotherapy; 2024 Apr; 26(4):393-403. PubMed ID: 38340106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond "medical tourism": Canadian companies marketing medical travel.
    Turner L
    Global Health; 2012 Jun; 8():16. PubMed ID: 22703873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.
    Nirwan RS; Albini TA; Sridhar J; Flynn HW; Kuriyan AE
    Ophthalmology; 2019 Oct; 126(10):1350-1355. PubMed ID: 30904542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles Isolated from Mesenchymal Stromal Cells Primed with Hypoxia: Novel Strategy in Regenerative Medicine.
    Pendse S; Kale V; Vaidya A
    Curr Stem Cell Res Ther; 2021; 16(3):243-261. PubMed ID: 32957892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims.
    Turner L; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Wang JC
    Stem Cell Reports; 2023 Nov; 18(11):2010-2015. PubMed ID: 37890484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration.
    Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study.
    Chavez J; Shah NA; Ruoss S; Cuomo RE; Ward SR; Mackey TK
    Stem Cell Res Ther; 2021 Mar; 12(1):189. PubMed ID: 33736697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travel.
    Turner L
    Global Health; 2011 Oct; 7():40. PubMed ID: 21995598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products.
    Laggner M; Gugerell A; Bachmann C; Hofbauer H; Vorstandlechner V; Seibold M; Gouya Lechner G; Peterbauer A; Madlener S; Demyanets S; Sorgenfrey D; Ostler T; Erb M; Mildner M; Ankersmit HJ
    Stem Cell Res Ther; 2020 Jan; 11(1):9. PubMed ID: 31900195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-Derived Stem Cells Secretome and Its Potential Application in "Stem Cell-Free Therapy".
    Trzyna A; Banaś-Ząbczyk A
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34199330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes and soluble secretome from hormone-treated endometrial epithelial cells direct embryo implantation.
    Gurung S; Greening DW; Catt S; Salamonsen L; Evans J
    Mol Hum Reprod; 2020 Jul; 26(7):510-520. PubMed ID: 32402079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application.
    Noor Azlan NAB; Vitus V; Nor Rashid N; Nordin F; Tye GJ; Wan Kamarul Zaman WS
    Cell Tissue Res; 2024 Mar; 395(3):227-250. PubMed ID: 38244032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.
    Murdoch B; Zarzeczny A; Caulfield T
    BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative mesenchymal stem cell-derived extracellular vesicles: A potential alternative to cell-based therapy in viral infection and disease damage control.
    Ipinmoroti AO; Pandit R; Matthews QL
    WIREs Mech Dis; 2022 Nov; 14(6):e1574. PubMed ID: 36065123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.